News
The European Medicines Agency's safety committee has concluded that a potentially dangerous eye condition is a very rare side ...
The European Medicines Agency's (EMA) safety committee has concluded that a potentially dangerous eye condition is a very ...
This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...
FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...
Many Americans struggle with being overweight, social stigmas still prevent people from talking to doctors and seeking ...
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...
An Ozempic warning has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for any women taking ...
Shares of Novo Nordisk Inc. (NYSE: NVO) are trading lower Tuesday after a new study raised concerns about a potential link ...
Women employed at Novo Nordisk A/S are now paid more on average than the men working at the maker of blockbuster drugs Wegovy ...
Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...
Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...
As consumers taking medications like Ozempic cut back on eating out, about 70% are spending more on cooking at home, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results